Tag: EphB4-ephrin-B2 inhibitor treatment

Home / EphB4-ephrin-B2 inhibitor treatment

Categories

New ways to fight recurrent head and neck cancer

Even with surgery,  radiotherapy, chemotherapy, and/or gene-targeted therapy (such as cetuximab), the five-year survival rate for locally advanced head and neck cancer is only 46%. Usually, the treat...
ephb4-ephrin-b2-inhibitor-treatment

Scan the code